Metsera, Inc.
Develops potent, long-acting oral & injectable therapies for obesity & metabolic diseases.
MTSR | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 3 WORLD TRADE CENTER, 10007 NEW YORK
- Website:
- https://metsera.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Metsera, Inc. is a clinical-stage biotechnology company focused on engineering, developing, and commercializing a new generation of therapies for obesity and related metabolic diseases. The company's portfolio consists of potent, ultra-long-acting, and scalable nutrient-stimulated hormone (NuSH) therapies, available as both injectable and oral candidates. Leveraging a proprietary peptide engineering platform, Metsera aims to improve drug potency, durability, and bioavailability. The company's integrated approach seeks to enhance treatment effectiveness and tolerability, lower barriers to long-term use, and deliver oral therapies with injectable-like performance.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Metsera, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Metsera, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Metsera, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
